Gábor Lakatos

969 total citations
21 papers, 570 citations indexed

About

Gábor Lakatos is a scholar working on Oncology, Surgery and Epidemiology. According to data from OpenAlex, Gábor Lakatos has authored 21 papers receiving a total of 570 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Surgery and 5 papers in Epidemiology. Recurrent topics in Gábor Lakatos's work include Pancreatic and Hepatic Oncology Research (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and Inflammatory Bowel Disease (3 papers). Gábor Lakatos is often cited by papers focused on Pancreatic and Hepatic Oncology Research (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and Inflammatory Bowel Disease (3 papers). Gábor Lakatos collaborates with scholars based in Hungary, Austria and Switzerland. Gábor Lakatos's co-authors include László Herszényi, István Hritz, Mária Zsófia Varga, Zsolt Tulassay, Pál Miheller, Zsolt Tulassay, G. Bodoky, Márk Juhász, Péter L. Lakatos and Györgyi Műzes and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and Annals of Oncology.

In The Last Decade

Gábor Lakatos

20 papers receiving 563 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gábor Lakatos Hungary 10 163 158 158 154 144 21 570
Joseph Loane United Kingdom 11 231 1.4× 75 0.5× 184 1.2× 54 0.4× 145 1.0× 19 609
Oksana Kowalczuk Poland 15 131 0.8× 70 0.4× 172 1.1× 136 0.9× 215 1.5× 51 720
Yih-Jyh Lin Taiwan 14 122 0.7× 61 0.4× 110 0.7× 104 0.7× 149 1.0× 23 501
Takahisa Kayahara Japan 10 102 0.6× 109 0.7× 394 2.5× 86 0.6× 321 2.2× 29 884
Jin Lu Tong China 12 92 0.6× 87 0.6× 240 1.5× 135 0.9× 160 1.1× 17 515
Álvaro Díaz‐González Spain 15 169 1.0× 62 0.4× 140 0.9× 88 0.6× 104 0.7× 41 567
Ibrahim Al Bakir United Kingdom 11 135 0.8× 64 0.4× 123 0.8× 64 0.4× 132 0.9× 26 514
Masataka Date Japan 14 171 1.0× 60 0.4× 176 1.1× 72 0.5× 386 2.7× 22 717
T Okudaira Japan 9 167 1.0× 63 0.4× 351 2.2× 126 0.8× 257 1.8× 13 757
Valeria Mariotti United States 12 156 1.0× 57 0.4× 233 1.5× 100 0.6× 197 1.4× 16 740

Countries citing papers authored by Gábor Lakatos

Since Specialization
Citations

This map shows the geographic impact of Gábor Lakatos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gábor Lakatos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gábor Lakatos more than expected).

Fields of papers citing papers by Gábor Lakatos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gábor Lakatos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gábor Lakatos. The network helps show where Gábor Lakatos may publish in the future.

Co-authorship network of co-authors of Gábor Lakatos

This figure shows the co-authorship network connecting the top 25 collaborators of Gábor Lakatos. A scholar is included among the top collaborators of Gábor Lakatos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gábor Lakatos. Gábor Lakatos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lakatos, Gábor, Claus‐Henning Köhne, & G. Bodoky. (2020). Current therapy of advanced colorectal cancer according to RAS/RAF mutational status. Cancer and Metastasis Reviews. 39(4). 1143–1157. 24 indexed citations
3.
Lakatos, Gábor, et al.. (2017). Efficacy and Safety of FOLFIRINOX in Locally Advanced Pancreatic Cancer. A Single Center Experience.. Pathology & Oncology Research. 23(4). 753–759. 19 indexed citations
4.
Koeberle, Dieter, Jean‐François Dufour, Gyula Demeter, et al.. (2016). Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29). Annals of Oncology. 27(5). 856–861. 102 indexed citations
5.
Koeberle, Dieter, Jean‐François Dufour, Gyula Demeter, et al.. (2014). Sorafenib with or without everolimus in patients with unresectable hepatocellular carcinoma (HCC): A randomized multicenter phase II trial (SAKK 77/08 and SASL 29).. Journal of Clinical Oncology. 32(15_suppl). 4099–4099. 3 indexed citations
6.
Lakatos, Gábor, et al.. (2014). Management of pancreatic cancer today. 1(1). 23–29. 1 indexed citations
7.
Herszényi, László, et al.. (2012). The Role of Inflammation and Proteinases in Tumor Progression. Digestive Diseases. 30(3). 249–254. 30 indexed citations
8.
Varga, Matthew G., J Láng, Márk Juhász, et al.. (2012). Significant decrease in prevalence of Helicobacter pylori and peptic ulcer disease over a 17-year period. Zeitschrift für Gastroenterologie. 50(5). 3 indexed citations
9.
Lakatos, Gábor, István Hritz, Mária Zsófia Varga, et al.. (2012). The Impact of Matrix Metalloproteinases and Their Tissue Inhibitors in Inflammatory Bowel Diseases. Digestive Diseases. 30(3). 289–295. 75 indexed citations
10.
Herszényi, László, István Hritz, Gábor Lakatos, Mária Zsófia Varga, & Zsolt Tulassay. (2012). The Behavior of Matrix Metalloproteinases and Their Inhibitors in Colorectal Cancer. International Journal of Molecular Sciences. 13(10). 13240–13263. 118 indexed citations
11.
Lakatos, Gábor, Katalin Müllner, István Hritz, et al.. (2011). Low bone mass in microscopic colitis. BMC Gastroenterology. 11(1). 58–58. 8 indexed citations
12.
Lakatos, Gábor, Ferenc Sípos, Pál Miheller, et al.. (2011). The Behavior of Matrix Metalloproteinase-9 in Lymphocytic Colitis, Collagenous Colitis and Ulcerative Colitis. Pathology & Oncology Research. 18(1). 85–91. 52 indexed citations
13.
Herszényi, László, Gábor Lakatos, & Zsolt Tulassay. (2010). Quality colonoscopy: assumptions and expectations. Orvosi Hetilap. 151(33). 1331–1339. 3 indexed citations
14.
Herszényi, László, Gábor Lakatos, & Zsolt Tulassay. (2010). Minőségi kolonoszkópia: feltételek és elvárások = Quality colonoscopy: assumptions and expectations. Repository of the Academy's Library (Library of the Hungarian Academy of Sciences). 1 indexed citations
15.
Lakatos, Gábor & Zsolt Tulassay. (2010). The epidemiology of pancreatic cancer. Orvosi Hetilap. 151(44). 1816–1822. 9 indexed citations
16.
Miheller, Pál, Györgyi Műzes, István Hritz, et al.. (2009). Comparison of the effects of 1,25 dihydroxyvitamin D and 25 hydroxyvitamin D on bone pathology and disease activity in Crohnʼs disease patients. Inflammatory Bowel Diseases. 15(11). 1656–1662. 103 indexed citations
17.
Lakatos, Gábor & Zsolt Tulassay. (2009). Probiotics in gastrointestinal disorders. Orvosi Hetilap. 150(19). 883–894. 2 indexed citations
18.
Hritz, István, Hajnalka Győrffy, Béla Molnár, et al.. (2008). Increased p53 Expression in the Malignant Transformation of Barrett’s Esophagus is Accompanied by an Upward Shift of the Proliferative Compartment. Pathology & Oncology Research. 15(2). 183–192. 11 indexed citations
19.
Miheller, Pál, et al.. (2008). Increased bone resorption and lower bone density in microscopic colitis. Zeitschrift für Gastroenterologie. 46(5). 1 indexed citations
20.
Lakatos, Gábor, László Herszényi, & Zsolt Tulassay. (2008). The safety of COX-2 inhibitors. Orvosi Hetilap. 149(33). 1539–1547. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026